Abstract
Integrating radiosensitivity index and triple-negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple-negative breast cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have